NEWTON, Mass.--(BUSINESS WIRE)-- #hypoparathyroidism--Extend Biosciences Announces Positive Data from Phase 1 Trial of EXT608 for the Treatment of Hypoparathyroidism

Extend Biosciences Announces Positive Data from Phase 1 Trial of EXT608 for the Treatment of Hypoparathyroidism

This "Hypoparathyroidism - Pipeline Insight, 2022" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Hypoparathyroidism pipeline landscape. The report outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Hypoparathyroidism pipeline landscape is provided which includes the disease overview and Hypoparathyroidism treatment guidelines. The assessment part of the report embraces, in depth Hypoparathyroidism commercial assessment and clinical assessment of the pipeline products under development. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Hypoparathyroidism collaborations, licensing, mergers and acquisition, funding, designations and other product related details. Report Highlights
The companies and academics are working to assess challenges and seek opportunities that could influence Hypoparathyroidism R&D. The therapies under development are focused on novel approaches to treat/improve Hypoparathyroidism. Hypoparathyroidism Emerging Drugs ChaptersThis segment of the Hypoparathyroidism report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery. It also helps to understand clinical trial details, expressive pharmacological action, agreements and collaborations, and the latest news and press releases. Hypoparathyroidism Emerging Drugs
TransCon PTH: Ascendis
PharmaTransConT PTH is an investigational prodrug of parathyroid hormone (PTH) in development as a once-daily hormone replacement therapy. It is designed to restore physiologic levels of PTH 24 hours a day. By doing so, we believe TransCon PTH can address both the short-term symptoms and long-term complications of hypoparathyroidism. The goal is to provide a PTH replacement therapy that normalizes serum and urinary calcium, as well as serum phosphate levels, and improves quality of life. TransCon PTH has orphan designation for the treatment of hypoparathyroidism in both the U.S. and Europe. Currently the drug is in Phase III stage of Clinial trial evaluation for the treatment of Hypoparathyroidism. Encaleret: Calcilytix
TherapeuticsEncaleret is an investigational small molecule antagonist of the calcium sensing receptor (CaSR). The CaSR is a G-protein-coupled receptor for which extracellular calcium is the primary ligand. The major physiologic role of the CaSR is to function conceptually as a 'calciostat' and maintain serum calcium levels by regulating the release of PTH and calcium reabsorption. Hypoparathyroidism: Therapeutic Assessment
This segment of the report provides insights about the different Hypoparathyroidism drugs segregated based on following parameters that define the scope of the report, such as:
Major Players in Hypoparathyroidism
There are approx. 10+ key companies which are developing the therapies for Hypoparathyroidism. The companies which have their Hypoparathyroidism drug candidates in the most advanced stage, i.e. phase III include, Ascendis Pharma. Phases
Late stage products (Phase III)
Mid-stage products (Phase II)
Discontinued & Inactive candidates
Route of Administration

Global Hypoparathyroidism Drug Pipeline Market Analysis 2022 Featuring Ascendis, Calcilytix Therapeutics, Amolyt, AEterna Zentaris, Entera Bio, Sigilon Therapeutics, ProLynx, &amp; Extend Biosciences - ResearchAndMarkets.com

Search jobs
21-Jun-2021
Hypoparathyroidism Treatment Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players- Extend Biosciences, Inc., Amgen, Inc., and BionPharma Inc., EnteraBio Ltd, and ProLynx Inc.
A recent market study published by Future Market Insights (FMI) on the hypoparathyroidism treatment market offers global industry analysis for 2016-2020 & opportunity assessment for 2021-2031. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the hypoparathyroidism treatment market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the  hypoparathyroidism treatment market  during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the hypoparathyroidism treatment market in the coming years. The report provides detailed information about the current and future growth prospects of hypoparathyroidism treatment market in the most comprehensive way for better understanding of readers. Key Segments of Hypoparathyroidism Treatment Market
FMI’s study on the hypoparathyroidism treatment market offers information divided into four important segments – product type, route of administration, distribution channel and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories. Product Type
Chapter 1 – Executive Summary
The report commences with the executive summary of the hypoparathyroidism treatment market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the hypoparathyroidism treatment market as well as the key trends impacting the market. Chapter 2 – Market Overview
Readers can find detailed taxonomy and product definition of the hypoparathyroidism treatment market, in this chapter, which help readers understand basic information about hypoparathyroidism treatment. Chapter 3 – Key Market Trends
This section highlights the key trends impacting the hypoparathyroidism treatment market, which will help readers understand the current trends and their impact on market growth. Chapter 4 – Key Success Factors
This chapter explains the hypoparathyroidism treatment pipeline analysis that are expected to create a positive impact on growth of the hypoparathyroidism treatment market during the forecast period. Chapter 5 – Market Background
This chapter explains the key macroeconomic factors that are expected to influence the growth of the hypoparathyroidism treatment market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the hypoparathyroidism treatment market, which include the drivers, restraints, and opportunity analysis. This chapter is expected to enable readers to understand the factors that are propelling the growth of the hypoparathyroidism treatment market, as well as those that are likely to hamper the growth of the hypoparathyroidism treatment market. The opportunity analysis for the hypoparathyroidism treatment will help readers understand the market opportunities, based on which they can plan their strategies. Chapter 6 – COVID19 Crisis Analysis
This section provides the current and expected impact of COVID19 on the hypoparathyroidism treatment market. Chapter 7 – Global Hypoparathyroidism Treatment Market Value (US$) Analysis 2016-2020 and Forecast 2021-2031
This section explains the global market value analysis and forecast for the hypoparathyroidism treatment market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2021), and an incremental $ opportunity for the forecast period (2021–2031). Chapter 8 – Global Hypoparathyroidism Treatment Market Analysis (2016-2020) & Opportunity Assessment (2021-2031), By Product Type
Based on Product type, the hypoparathyroidism treatment market is segmented into parathyroid hormone, vitamin D analogue, and calcium supplements. In this chapter, readers can find information about a detailed analysis of the market by different products available for hypoparathyroidism treatment and their growth over the forecast period. Chapter 9 – Global Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment, 2021-2031, By Route of Administration
Based on route of administration, the hypoparathyroidism treatment market is segmented into oral and parenteral route of administration in this chapter, readers can find information on market attractive analysis based on route of administration. Chapter 10 – Global Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment, 2021-2031, By Distribution Channel
Based on distribution channel, the hypoparathyroidism treatment market is segmented into hospital pharmacy, retail pharmacy, and online sales in this chapter, readers can find information on market attractive analysis based on distribution channel. Chapter 11 – Global Hypoparathyroidism Treatment Market Analysis 2016-2021 & Opportunity Assessment 2021-2031, By Region
This chapter explains how the hypoparathyroidism treatment market will grow across various geographic regions such as North America, Latin America, Europe, Asia Pacific and Middle East & Africa. Chapter 12 – North America Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment 2021-2031
This chapter includes a detailed analysis of the growth of the North America hypoparathyroidism treatment market along with the country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on product type, route of administration, distribution channel, and country hypoparathyroidism treatment in the North American region
Chapter 13 – Latin America Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment 2021-2022
This chapter includes the growth prospects of the hypoparathyroidism treatment market in leading countries such as Brazil, Mexico, and the rest of Latin America. Readers can find thorough information about the growth parameters of the Latin America hypoparathyroidism treatment market during 2021-2031. Chapter 14 – Europe Hypoparathyroidism Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
Important growth prospects of the hypoparathyroidism treatment market based on development of new product development, regulatory approvals, and country in several European countries such as the U.K., Germany, France, Italy, Spain, and Rest of Europe are included in this chapter. Chapter 15 – Asia Pacific Hypoparathyroidism Treatment Market Analysis 2016-2020 and Forecast 2021-2031
China, India, Japan, Australia, and New Zealand, and the rest of Asia Pacific that are the prime subjects of assessment to obtain the growth prospects of the Asia Pacific hypoparathyroidism treatment market. Also, in this chapter, readers can find thorough information about the growth parameters of the Asia Pacific hypoparathyroidism treatment market during 2031. Chapter 16 – MEA Hypoparathyroidism Treatments Market Analysis 2016-2020 & Opportunity Assessment 2021-2031
This chapter provides information on how the hypoparathyroidism treatment market will grow in the major countries in MEA region, such as GCC Countries, South Africa, and Rest of MEA during 2021-2031
Chapter 17 – Key and Emerging Countries Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment 2021-2022
This chapter provides information on how the hypoparathyroidism treatment market will grow in the major countries across the world during 2021-2031. Request for Report Ask A Question @  https://www.futuremarketinsights.com/ask-question/rep-gb-7857
Chapter 18 – Market Structure Analysis
This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key player operating in hypoparathyroidism treatment market. Chapter 19 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the hypoparathyroidism treatment includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd, Ascendis Pharma A/S, EnteraBio Ltd, Extend Biosciences, Inc., Amgen, Inc., and BionPharma Inc., EnteraBio Ltd, and ProLynx Inc.,
Chapter 20 – Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report. Chapter 21 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the hypoparathyroidism treatment market. Explore Wide-ranging Coverage of FMI’s Healthcare Landscape
Dermal Fillers Market  – Diverse applications of dermal fillers in helping to improve an individual’s appeatance have been sustaining growth of the market. According to FMI, dermal fillers market is projected to exhibit 2.9% CAGR between 2021 and 2031. Electrophysiology Market  – Cardiac complications are grim health concerns, reported by the World Health Organization (WHO) for being the leading cause of death. Various interventional procedures and implantable cardiac devices are instrumentally implemented for the management of the cardiac arrhythmias. Respiratory Devices Market  – According to the World Health Organization (WHO), chronic obstructive pulmonary diseases (COPD) is a major health concern and is one of the leading causes of death globally. Technologically advanced medical devices and effective drugs have become key to the management of COPD and other respiratory disorders. About FMI       
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI  is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest  market research reports  and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact Us

Hypoparathyroidism Treatment Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players- Extend Biosciences, Inc., Amgen, Inc., and BionPharma Inc., EnteraBio Ltd, and ProLynx Inc.

Search jobs
17-Jun-2021
Hypoparathyroidism Treatment Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players- Extend Biosciences, Inc., Amgen, Inc., and BionPharma Inc., EnteraBio Ltd, and ProLynx Inc.
A recent market study published by Future Market Insights (FMI) on the hypoparathyroidism treatment market offers global industry analysis for 2016-2020 & opportunity assessment for 2021-2031. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the hypoparathyroidism treatment market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the  hypoparathyroidism treatment market  during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the hypoparathyroidism treatment market in the coming years. The report provides detailed information about the current and future growth prospects of hypoparathyroidism treatment market in the most comprehensive way for better understanding of readers. Key Segments of Hypoparathyroidism Treatment Market
FMI’s study on the hypoparathyroidism treatment market offers information divided into four important segments – product type, route of administration, distribution channel and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories. Product Type
Chapter 1 – Executive Summary
The report commences with the executive summary of the hypoparathyroidism treatment market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the hypoparathyroidism treatment market as well as the key trends impacting the market. Chapter 2 – Market Overview
Readers can find detailed taxonomy and product definition of the hypoparathyroidism treatment market, in this chapter, which help readers understand basic information about hypoparathyroidism treatment. Chapter 3 – Key Market Trends
This section highlights the key trends impacting the hypoparathyroidism treatment market, which will help readers understand the current trends and their impact on market growth. Chapter 4 – Key Success Factors
This chapter explains the hypoparathyroidism treatment pipeline analysis that are expected to create a positive impact on growth of the hypoparathyroidism treatment market during the forecast period. Chapter 5 – Market Background
This chapter explains the key macroeconomic factors that are expected to influence the growth of the hypoparathyroidism treatment market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the hypoparathyroidism treatment market, which include the drivers, restraints, and opportunity analysis. This chapter is expected to enable readers to understand the factors that are propelling the growth of the hypoparathyroidism treatment market, as well as those that are likely to hamper the growth of the hypoparathyroidism treatment market. The opportunity analysis for the hypoparathyroidism treatment will help readers understand the market opportunities, based on which they can plan their strategies. Chapter 6 – COVID19 Crisis Analysis
This section provides the current and expected impact of COVID19 on the hypoparathyroidism treatment market. Chapter 7 – Global Hypoparathyroidism Treatment Market Value (US$) Analysis 2016-2020 and Forecast 2021-2031
This section explains the global market value analysis and forecast for the hypoparathyroidism treatment market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2021), and an incremental $ opportunity for the forecast period (2021–2031). Chapter 8 – Global Hypoparathyroidism Treatment Market Analysis (2016-2020) & Opportunity Assessment (2021-2031), By Product Type
Based on Product type, the hypoparathyroidism treatment market is segmented into parathyroid hormone, vitamin D analogue, and calcium supplements. In this chapter, readers can find information about a detailed analysis of the market by different products available for hypoparathyroidism treatment and their growth over the forecast period. Chapter 9 – Global Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment, 2021-2031, By Route of Administration
Based on route of administration, the hypoparathyroidism treatment market is segmented into oral and parenteral route of administration in this chapter, readers can find information on market attractive analysis based on route of administration. Chapter 10 – Global Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment, 2021-2031, By Distribution Channel
Based on distribution channel, the hypoparathyroidism treatment market is segmented into hospital pharmacy, retail pharmacy, and online sales in this chapter, readers can find information on market attractive analysis based on distribution channel. Chapter 11 – Global Hypoparathyroidism Treatment Market Analysis 2016-2021 & Opportunity Assessment 2021-2031, By Region
This chapter explains how the hypoparathyroidism treatment market will grow across various geographic regions such as North America, Latin America, Europe, Asia Pacific and Middle East & Africa. Chapter 12 – North America Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment 2021-2031
This chapter includes a detailed analysis of the growth of the North America hypoparathyroidism treatment market along with the country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on product type, route of administration, distribution channel, and country hypoparathyroidism treatment in the North American region
Chapter 13 – Latin America Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment 2021-2022
This chapter includes the growth prospects of the hypoparathyroidism treatment market in leading countries such as Brazil, Mexico, and the rest of Latin America. Readers can find thorough information about the growth parameters of the Latin America hypoparathyroidism treatment market during 2021-2031. Chapter 14 – Europe Hypoparathyroidism Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
Important growth prospects of the hypoparathyroidism treatment market based on development of new product development, regulatory approvals, and country in several European countries such as the U.K., Germany, France, Italy, Spain, and Rest of Europe are included in this chapter. Chapter 15 – Asia Pacific Hypoparathyroidism Treatment Market Analysis 2016-2020 and Forecast 2021-2031
China, India, Japan, Australia, and New Zealand, and the rest of Asia Pacific that are the prime subjects of assessment to obtain the growth prospects of the Asia Pacific hypoparathyroidism treatment market. Also, in this chapter, readers can find thorough information about the growth parameters of the Asia Pacific hypoparathyroidism treatment market during 2031. Chapter 16 – MEA Hypoparathyroidism Treatments Market Analysis 2016-2020 & Opportunity Assessment 2021-2031
This chapter provides information on how the hypoparathyroidism treatment market will grow in the major countries in MEA region, such as GCC Countries, South Africa, and Rest of MEA during 2021-2031
Chapter 17 – Key and Emerging Countries Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment 2021-2022
This chapter provides information on how the hypoparathyroidism treatment market will grow in the major countries across the world during 2021-2031. Request for Report Ask A Question @  https://www.futuremarketinsights.com/ask-question/rep-gb-7857
Chapter 18 – Market Structure Analysis
This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key player operating in hypoparathyroidism treatment market. Chapter 19 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the hypoparathyroidism treatment includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd, Ascendis Pharma A/S, EnteraBio Ltd, Extend Biosciences, Inc., Amgen, Inc., and BionPharma Inc., EnteraBio Ltd, and ProLynx Inc.,
Chapter 20 – Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report. Chapter 21 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the hypoparathyroidism treatment market. Explore Wide-ranging Coverage of FMI’s Healthcare Landscape
Dermal Fillers Market  – Diverse applications of dermal fillers in helping to improve an individual’s appeatance have been sustaining growth of the market. According to FMI, dermal fillers market is projected to exhibit 2.9% CAGR between 2021 and 2031. Electrophysiology Market  – Cardiac complications are grim health concerns, reported by the World Health Organization (WHO) for being the leading cause of death. Various interventional procedures and implantable cardiac devices are instrumentally implemented for the management of the cardiac arrhythmias. Respiratory Devices Market  – According to the World Health Organization (WHO), chronic obstructive pulmonary diseases (COPD) is a major health concern and is one of the leading causes of death globally. Technologically advanced medical devices and effective drugs have become key to the management of COPD and other respiratory disorders. About FMI       
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI  is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest  market research reports  and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact Us

Search jobs
04-May-2021
Hypoparathyroidism Treatment Market In-Depth Analysis on Size, Cost Structure and Prominent Key Players- Extend Biosciences, Inc., Amgen, Inc., and BionPharma Inc., EnteraBio Ltd, and ProLynx Inc.
A recent market study published by Future Market Insights (FMI) on the hypoparathyroidism treatment market offers global industry analysis for 2016-2020 & opportunity assessment for 2021-2031. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the hypoparathyroidism treatment market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may make a huge impact on the development of the hypoparathyroidism treatment market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the hypoparathyroidism treatment market in the coming years. The report provides detailed information about the current and future growth prospects of hypoparathyroidism treatment market in the most comprehensive way for better understanding of readers. Key Segments of Hypoparathyroidism Treatment Market
FMI’s study on the hypoparathyroidism treatment market offers information divided into four important segments – product type, route of administration, distribution channel and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories. Product Type
Chapter 1 – Executive Summary
The report commences with the executive summary of the hypoparathyroidism treatment market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the hypoparathyroidism treatment market as well as the key trends impacting the market. Chapter 2 – Market Overview
Readers can find detailed taxonomy and product definition of the hypoparathyroidism treatment market, in this chapter, which help readers understand basic information about hypoparathyroidism treatment. Chapter 3 – Key Market Trends
This section highlights the key trends impacting the hypoparathyroidism treatment market, which will help readers understand the current trends and their impact on market growth. Chapter 4 – Key Success Factors
This chapter explains the hypoparathyroidism treatment pipeline analysis that are expected to create a positive impact on growth of the hypoparathyroidism treatment market during the forecast period. Chapter 5 – Market Background
This chapter explains the key macroeconomic factors that are expected to influence the growth of the hypoparathyroidism treatment market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the hypoparathyroidism treatment market, which include the drivers, restraints, and opportunity analysis. This chapter is expected to enable readers to understand the factors that are propelling the growth of the hypoparathyroidism treatment market, as well as those that are likely to hamper the growth of the hypoparathyroidism treatment market. The opportunity analysis for the hypoparathyroidism treatment will help readers understand the market opportunities, based on which they can plan their strategies. Chapter 6 – COVID19 Crisis Analysis
This section provides the current and expected impact of COVID19 on the hypoparathyroidism treatment market. Chapter 7 – Global Hypoparathyroidism Treatment Market Value (US$) Analysis 2016-2020 and Forecast 2021-2031
This section explains the global market value analysis and forecast for the hypoparathyroidism treatment market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2021), and an incremental $ opportunity for the forecast period (2021–2031). Chapter 8 – Global Hypoparathyroidism Treatment Market Analysis (2016-2020) & Opportunity Assessment (2021-2031), By Product Type
Based on Product type, the hypoparathyroidism treatment market is segmented into parathyroid hormone, vitamin D analogue, and calcium supplements. In this chapter, readers can find information about a detailed analysis of the market by different products available for hypoparathyroidism treatment and their growth over the forecast period. Chapter 9 – Global Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment, 2021-2031, By Route of Administration
Based on route of administration, the hypoparathyroidism treatment market is segmented into oral and parenteral route of administration in this chapter, readers can find information on market attractive analysis based on route of administration. Chapter 10 – Global Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment, 2021-2031, By Distribution Channel
Based on distribution channel, the hypoparathyroidism treatment market is segmented into hospital pharmacy, retail pharmacy, and online sales in this chapter, readers can find information on market attractive analysis based on distribution channel. Chapter 11 – Global Hypoparathyroidism Treatment Market Analysis 2016-2021 & Opportunity Assessment 2021-2031, By Region
This chapter explains how the hypoparathyroidism treatment market will grow across various geographic regions such as North America, Latin America, Europe, Asia Pacific and Middle East & Africa. Chapter 12 – North America Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment 2021-2031
This chapter includes a detailed analysis of the growth of the North America hypoparathyroidism treatment market along with the country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on product type, route of administration, distribution channel, and country hypoparathyroidism treatment in the North American region
Chapter 13 – Latin America Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment 2021-2022
This chapter includes the growth prospects of the hypoparathyroidism treatment market in leading countries such as Brazil, Mexico, and the rest of Latin America. Readers can find thorough information about the growth parameters of the Latin America hypoparathyroidism treatment market during 2021-2031. Chapter 14 – Europe Hypoparathyroidism Treatment Market Analysis 2015-2019 & Opportunity Assessment 2020-2030
Important growth prospects of the hypoparathyroidism treatment market based on development of new product development, regulatory approvals, and country in several European countries such as the U.K., Germany, France, Italy, Spain, and Rest of Europe are included in this chapter. Chapter 15 – Asia Pacific Hypoparathyroidism Treatment Market Analysis 2016-2020 and Forecast 2021-2031
China, India, Japan, Australia, and New Zealand, and the rest of Asia Pacific that are the prime subjects of assessment to obtain the growth prospects of the Asia Pacific hypoparathyroidism treatment market. Also, in this chapter, readers can find thorough information about the growth parameters of the Asia Pacific hypoparathyroidism treatment market during 2031. Chapter 16 – MEA Hypoparathyroidism Treatments Market Analysis 2016-2020 & Opportunity Assessment 2021-2031
This chapter provides information on how the hypoparathyroidism treatment market will grow in the major countries in MEA region, such as GCC Countries, South Africa, and Rest of MEA during 2021-2031
Chapter 17 – Key and Emerging Countries Hypoparathyroidism Treatment Market Analysis 2016-2020 & Opportunity Assessment 2021-2022
This chapter provides information on how the hypoparathyroidism treatment market will grow in the major countries across the world during 2021-2031. Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-7857
Chapter 18 – Market Structure Analysis
This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key player operating in hypoparathyroidism treatment market. Chapter 19 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the hypoparathyroidism treatment includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Takeda Pharmaceutical Company Limited, F. Hoffmann-La Roche Ltd, Ascendis Pharma A/S, EnteraBio Ltd, Extend Biosciences, Inc., Amgen, Inc., and BionPharma Inc., EnteraBio Ltd, and ProLynx Inc.,
Chapter 20 – Assumptions and Acronyms Used
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report. Chapter 21 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the hypoparathyroidism treatment market. Explore Wide-ranging Coverage of FMI’s HealthcareLandscape
Dermal Fillers Market – Diverse applications of dermal fillers in helping to improve an individual’sappeatance have been sustaining growth of the market. According to FMI, dermalfillers market is projected to exhibit 2.9% CAGR between 2021 and 2031. Electrophysiology Market – Cardiac complications are grim health concerns, reported by the World HealthOrganization (WHO) for being the leading cause of death. Various interventionalprocedures and implantable cardiac devices are instrumentallyimplemented for the management of the cardiac arrhythmias. Respiratory Devices Market – According to the World Health Organization (WHO), chronic obstructivepulmonary diseases (COPD) is a major health concern and is one of the leadingcauses of death globally. Technologically advanced medical devices andeffective drugs have become key to the management of COPD and other respiratorydisorders. About FMI       
Future Market Insights (FMI) is a leading provider of marketintelligence and consulting services, serving clients in over 150countries. FMI  isheadquartered in Dubai, the global financial capital, and has delivery centersin the U.S. and India. FMI’s latest  marketresearch reports  and industry analysis help businesses navigatechallenges and make critical decisions with confidence and clarity amidstbreakneck competition. Our customized and syndicated market research reportsdeliver actionable insights that drive sustainable growth. A team of expert-ledanalysts at FMI continuously tracks emerging trends and events in a broad rangeof industries to ensure that our clients prepare for the evolving needs oftheir consumers. ContactUs

Neotropix

Purdue Pharmaceuticals

Grant

Grant - II

Extend Biosciences is a biotechnology company that develops a drug delivery platform technology that improves the pharmacokinetic properties of peptides and proteins. Its technologies enable the efficient and sustained delivery of peptides and proteins. The company was founded in 2010 and is based in Newton, Massachusetts.

Name	Work History	Title	Status
Laura Hales	Neotropix, and Purdue Pharmaceuticals	Founder	Current
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more

Name	Laura Hales	Subscribe to see more	Subscribe to see more
Work History	Neotropix, and Purdue Pharmaceuticals	Subscribe to see more	Subscribe to see more
Title	Founder	Subscribe to see more	Subscribe to see more
Status	Current	Subscribe to see more	Subscribe to see more

Wells Fargo Success Story

Professional Services

Platform Overview

Extend Biosciences

Executives

Extend Biosciences Management Team

3 Team Members